Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: a pilot study

Karim Zouaoui Boudjeltia, Brice Faraut, Patricia Stenuit, Maria José Esposito, Michal Dyzma, Dany Brohée, Jean Ducobu, Michel Vanhaeverbeek, Myriam Kerkhofs, Karim Zouaoui Boudjeltia, Brice Faraut, Patricia Stenuit, Maria José Esposito, Michal Dyzma, Dany Brohée, Jean Ducobu, Michel Vanhaeverbeek, Myriam Kerkhofs

Abstract

Objectives: This study examines the effects of sleep restricted to four hours for three consecutive nights on blood parameters, known to be associated with cardiovascular risk, in young healthy men.

Material and methods: Eight young healthy men (age 24.5 +/- 3.3 years) were studied in the sleep restricted group. Nine young healthy men (age 24 +/- 2 years) were included in the control group and spent the days and nights in the sleep lab, while sleeping eight hours/night. One baseline night was followed by three nights of sleep restriction to four hours and by one recovery night of eight hours. Blood samplings were performed after the baseline night and after the third night of sleep restriction or without restriction for the control group.

Results: A significant increase in white blood cells (WBC) (5.79 +/- 1.05 vs. 6.89 +/- 1.31 10(3) cell/microl, p = 0.03), and neutrophils (3.17 +/- 0.69 vs 4.24 +/- 0.97 10(3) cell/microl, p = 0.01) was observed after the third night of sleep restriction. Other blood parameters were not affected. No significant variation was observed in the control group.

Conclusion: Sleep restriction affected WBC count, mainly neutrophils, considered as risk factor for cardiovascular disease. Stress induced by the short term sleep restriction could be involved in this observation.

Keywords: cardiovascular risk; cholesterol; men; neutrophils; sleep restriction.

References

    1. Brohée D, Vanhaeverbeek M, Kennes B, et al. Leukocyte and lymphocyte subsets after a short pharmacological stress by intravenous epinephrine and hydrocortisone in healthy humans. Intern J Neurosci. 1990;53:53–62.
    1. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001;54:316–22.
    1. Danesh J, Collins R, Appleby P, et al. C-reactive protein, albumin or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477–82.
    1. Dinges DF, Douglas S, Zaugg L, et al. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest. 1994;93:1930–9.
    1. Elkind MSV, Sciacca RR, Boden-Albala B, et al. Leukocytes count is associated with reduced endothelial reactivity. Atherosclerosis. 2005;181:329–38.
    1. Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:1102–7.
    1. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47:833–9.
    1. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease and death: the NHANES I epidemiologic follow-up study. Am Heart J. 1993;125:855–63.
    1. Gomez-Merino D, Drogou C, Chennaoui M, et al. Effects of combinated stress during intense training on cellular immunity, hormones and respiratory infections. Neuroimmunomodulation. 2005;12:164–72.
    1. Grimm RH, Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all cause mortality. JAMA. 1985;254:1932–7.
    1. Harlan JM, Killen PD, Harker LA, et al. NEutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest. 1981;68:1394–403.
    1. Heslop P, Davey Smith G, Metcalfe C, et al. Sleep duration and mortality: the effects of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med. 2002;3:305–14.
    1. Iber C, Ancoli-Israel S, Chesson AL, et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications. Westchester, Ill: American Academy of Sleep Medicine; 2007.
    1. Irwin M, Thompson J, Miller C, et al. Effects of sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab. 1999;84:1979–85.
    1. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease: insight from the Framingham Study. JAMA. 1992;267:1253–6.
    1. Kerkhofs M, Zouaoui Boudjeltia K, Stenuit P, et al. Sleep restriction increases blood neutrophils, total cholesterol and Low Density Lipoprotein Cholesterol in postmenopausal women: a preliminary study. Maturitas. 2007;56:212–5.
    1. Lee CD, Folsom AR, Nieto FJ, et al. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-american and white men and women: atherosclerosis risk in communities study. Am J Epidemiol. 2001;154:758–64.
    1. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003;169:203–14.
    1. Ludwig PW, Hunnighake DB, Hoidal JR. Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet. 1982;2:348–50.
    1. Mehta J, Dinerman J, Mehta P, et al. Neutrophil function in ischemic heart disease. Circulation. 1989;79:549–56.
    1. Meier-Ewert HK, Ridker P, Rifai N, et al. Effects of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43:678–83.
    1. Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137:49–53.
    1. Phillips AN, Neaton JD, Cook DG, et al. Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol. 1992;136:59–70.
    1. Sweetman PM, Thomas HF, Yarnell JW, et al. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and speedwell studies. Am J Epidemiol. 1997;145:416–21.
    1. Weissman G, Smolen JE, Korchak HM. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med. 1980;303:27–34.
    1. Zalokar JB, Richard JL, Claude JR. Leulocyte count, smoking, and myocardial infarction. N Engl J Med. 1981;304:465–8.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다